We are live on ! Find out more
MRNY icon

YieldMax MRNA Option Income Strategy ETF

6 hedge funds and large institutions have $26.5M invested in YieldMax MRNA Option Income Strategy ETF in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more capital invested

Capital invested by funds: $11.4M → $26.5M (+$15.2M)

100% more funds holding

Funds holding: 3 → 6 (+3)

5.55% more ownership

Funds ownership: 1.89% → 7.44% (+5.5%)

Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MRNY Hedge Fund Activity: Q4 2024 in Review

6 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q4 2024, worth a combined $26.5M — up 134% from $11.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MRNY positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Tidal Investments, adding an estimated $22.7M.

  • 6 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q4 2024, up from 3 in Q3 2024.
  • Funds reported $26.5M of YieldMax MRNA Option Income Strategy ETF stock for Q4 2024, up 134% quarter-over-quarter.
  • 3 funds opened new YieldMax MRNA Option Income Strategy ETF positions in Q4 2024 and 0 closed out, a net change of +3 holders.
  • The largest YieldMax MRNA Option Income Strategy ETF buyer in Q4 2024 was Tidal Investments, an estimated $22.7M added.

Based on aggregated 13F filings for Q4 2024.